Phosphodiesterase Type 4 Inhibitors Cause Proinflammatory Effects in Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phosphodiesterase Type 4 Inhibitors Cause Proinflammatory Effects in Vivo

Published:2006-07-21 Issue:1 Volume:319 Page:468-476
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

McCluskie Kerryn,Klein Uwe,Linnevers Chris,Ji Yu-hua,Yang Alfred,Husfeld Craig,Thomas G. Roger

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Pharmacology ofN-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor

2. PPAR- agonists as therapy for diseases involving airway neutrophilia

3. The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10

4. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung

5. Identification and Function of Cyclic Nucleotide Phosphodiesterase Isoenzymes in Airway Epithelial Cells

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epilobiumpyrricholophum Extract Suppresses Porcine Pancreatic Elastase and Cigarette Smoke Extract-Induced Inflammatory response in a Chronic Obstructive Pulmonary Disease Model;Foods;2021-11-26

2. Detrimental Effects of an Inhaled Phosphodiesterase-4 Inhibitor on Lung Inflammation in Ventilated Preterm Lambs Exposed to Chorioamnionitis Are Dose Dependent;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2019-12-01

3. Phosphodiesterases as therapeutic targets for respiratory diseases;Pharmacology & Therapeutics;2019-05

4. The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition;Experimental Dermatology;2018-12-12

5. The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease;Expert Opinion on Drug Discovery;2016-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3